However, while these studies support therapeutic targeting of the TAM family of RTKs to reduce immune suppression, it is noted that deletion of PROS1 in macrophages can also lead to enhanced metastasis, in part through increased production of IL10 that enhances the survival and invasive potential of tumor cells [122]. This evidence concerns the gene PROS1 and neoplasm.